MENU
GNPX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genprex (GNPX) Ownership - Who owns Genprex?
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
3300 Bee Cave Road
Phone
+1 877 774-4679
Employees
26
Web
https://www.genprex.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.62M
P/E Ratio
N/A
Total Cash
1.49M
Projected Growth
N/A
Total Debt
279.29K
Revenue
N/A
Risk (Beta)
-0.70
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GNPX
Capitalization
3.62M
P/E Ratio
N/A
Risk (Beta)
-0.70
Dividend Yield
N/A
Total Cash
1.49M
Total Cash/Share
0.17
Total Debt
279K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.67M
P/B Ratio
2.17
Cash Flow
N/A
Earnings
-10.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5.49K
Current Ratio
0.86
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-22.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-221.01
Shares Held By Institutions
295K
Shares Outstanding - Current
8.51M
Total Liabilities
2.24M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-49.319
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of molecular therapies for cancer treatment
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3300 Bee Cave Road
Phone
+1 877 774-4679
Employees
26
Web
https://www.genprex.com